Rosiglitazone reduces cell invasiveness by inducing MKP-1 in human U87MG glioma cells

Hsun Jin Jan, Chin Cheng Lee, Yu Min Lin, Jing Huei Lai, Hen Wei Wei, Horng Mo Lee

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

We sought to investigate the molecular mechanisms by which rosiglitazone (RGZ) inhibits cell invasion in human glioma cells. In this study, we found that RGZ attenuated MMP-2 protein levels, MMP-2 gelatinolytic activity, and cell invasiveness through a PPAR-γ independent pathway. RGZ increased mitogen activated protein kinase phosphatase-1 (MKP-1) expression. The addition of triptolide (a diterpenoid triepoxide, which blocked MKP-1 induction) abolished the inhibitory effects by RGZ. Furthermore, we demonstrated that the knock down of MKP-1 by MKP-1 specific small interference RNA reversed the reduction of MMP-2 secretion, and of cell invasiveness by RGZ. In contrast, the stable expression of MKP-1 in glioma cell lines decreased MMP-2 activity and cell invasiveness. These results suggest that RGZ may mediate the inhibitory effects through MKP-1 induction. Thus, MKP-1 could be a potential target in glioma therapy.

Original languageEnglish
Pages (from-to)141-148
Number of pages8
JournalCancer Letters
Volume277
Issue number2
DOIs
Publication statusPublished - May 18 2009

Fingerprint

rosiglitazone
Mitogen-Activated Protein Kinase Phosphatases
Dual Specificity Phosphatase 1
Glioma
Matrix Metalloproteinases
Peroxisome Proliferator-Activated Receptors
Diterpenes
RNA Interference

Keywords

  • Glioma
  • Matrix metalloproteinase
  • Mitogen activated protein kinase phosphatase-1

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Rosiglitazone reduces cell invasiveness by inducing MKP-1 in human U87MG glioma cells. / Jan, Hsun Jin; Lee, Chin Cheng; Lin, Yu Min; Lai, Jing Huei; Wei, Hen Wei; Lee, Horng Mo.

In: Cancer Letters, Vol. 277, No. 2, 18.05.2009, p. 141-148.

Research output: Contribution to journalArticle

Jan, Hsun Jin ; Lee, Chin Cheng ; Lin, Yu Min ; Lai, Jing Huei ; Wei, Hen Wei ; Lee, Horng Mo. / Rosiglitazone reduces cell invasiveness by inducing MKP-1 in human U87MG glioma cells. In: Cancer Letters. 2009 ; Vol. 277, No. 2. pp. 141-148.
@article{9772abd690f046a79c3eeb0aca7eb5f4,
title = "Rosiglitazone reduces cell invasiveness by inducing MKP-1 in human U87MG glioma cells",
abstract = "We sought to investigate the molecular mechanisms by which rosiglitazone (RGZ) inhibits cell invasion in human glioma cells. In this study, we found that RGZ attenuated MMP-2 protein levels, MMP-2 gelatinolytic activity, and cell invasiveness through a PPAR-γ independent pathway. RGZ increased mitogen activated protein kinase phosphatase-1 (MKP-1) expression. The addition of triptolide (a diterpenoid triepoxide, which blocked MKP-1 induction) abolished the inhibitory effects by RGZ. Furthermore, we demonstrated that the knock down of MKP-1 by MKP-1 specific small interference RNA reversed the reduction of MMP-2 secretion, and of cell invasiveness by RGZ. In contrast, the stable expression of MKP-1 in glioma cell lines decreased MMP-2 activity and cell invasiveness. These results suggest that RGZ may mediate the inhibitory effects through MKP-1 induction. Thus, MKP-1 could be a potential target in glioma therapy.",
keywords = "Glioma, Matrix metalloproteinase, Mitogen activated protein kinase phosphatase-1",
author = "Jan, {Hsun Jin} and Lee, {Chin Cheng} and Lin, {Yu Min} and Lai, {Jing Huei} and Wei, {Hen Wei} and Lee, {Horng Mo}",
year = "2009",
month = "5",
day = "18",
doi = "10.1016/j.canlet.2008.11.033",
language = "English",
volume = "277",
pages = "141--148",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Rosiglitazone reduces cell invasiveness by inducing MKP-1 in human U87MG glioma cells

AU - Jan, Hsun Jin

AU - Lee, Chin Cheng

AU - Lin, Yu Min

AU - Lai, Jing Huei

AU - Wei, Hen Wei

AU - Lee, Horng Mo

PY - 2009/5/18

Y1 - 2009/5/18

N2 - We sought to investigate the molecular mechanisms by which rosiglitazone (RGZ) inhibits cell invasion in human glioma cells. In this study, we found that RGZ attenuated MMP-2 protein levels, MMP-2 gelatinolytic activity, and cell invasiveness through a PPAR-γ independent pathway. RGZ increased mitogen activated protein kinase phosphatase-1 (MKP-1) expression. The addition of triptolide (a diterpenoid triepoxide, which blocked MKP-1 induction) abolished the inhibitory effects by RGZ. Furthermore, we demonstrated that the knock down of MKP-1 by MKP-1 specific small interference RNA reversed the reduction of MMP-2 secretion, and of cell invasiveness by RGZ. In contrast, the stable expression of MKP-1 in glioma cell lines decreased MMP-2 activity and cell invasiveness. These results suggest that RGZ may mediate the inhibitory effects through MKP-1 induction. Thus, MKP-1 could be a potential target in glioma therapy.

AB - We sought to investigate the molecular mechanisms by which rosiglitazone (RGZ) inhibits cell invasion in human glioma cells. In this study, we found that RGZ attenuated MMP-2 protein levels, MMP-2 gelatinolytic activity, and cell invasiveness through a PPAR-γ independent pathway. RGZ increased mitogen activated protein kinase phosphatase-1 (MKP-1) expression. The addition of triptolide (a diterpenoid triepoxide, which blocked MKP-1 induction) abolished the inhibitory effects by RGZ. Furthermore, we demonstrated that the knock down of MKP-1 by MKP-1 specific small interference RNA reversed the reduction of MMP-2 secretion, and of cell invasiveness by RGZ. In contrast, the stable expression of MKP-1 in glioma cell lines decreased MMP-2 activity and cell invasiveness. These results suggest that RGZ may mediate the inhibitory effects through MKP-1 induction. Thus, MKP-1 could be a potential target in glioma therapy.

KW - Glioma

KW - Matrix metalloproteinase

KW - Mitogen activated protein kinase phosphatase-1

UR - http://www.scopus.com/inward/record.url?scp=62849099510&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62849099510&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2008.11.033

DO - 10.1016/j.canlet.2008.11.033

M3 - Article

VL - 277

SP - 141

EP - 148

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 2

ER -